Incremental benefit of preoperative EUS for the detection of pancreatic neuroendocrine tumors: a meta-analysis

被引:53
作者
James, Paul D. [1 ,2 ,3 ]
Tsolakis, Apostolos V. [3 ,4 ]
Zhang, Mei [4 ]
Belletrutti, Paul J. [3 ]
Mohamed, Rachid [3 ]
Roberts, Derek J. [5 ]
Heitman, Steven J. [3 ]
机构
[1] Univ Ottawa, Dept Med, Ottawa, ON K1H 1A2, Canada
[2] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON K1H 1A2, Canada
[3] Univ Calgary, Dept Med & Community Hlth Sci, Calgary, AB, Canada
[4] Uppsala Univ, Dept Med Sci, Sect Endocrine Oncol, Uppsala, Sweden
[5] Univ Calgary, Dept Surg & Community Hlth Sci, Calgary, AB, Canada
关键词
ENETS CONSENSUS GUIDELINES; ENDOCRINE NEOPLASIA TYPE-1; ENDOSCOPIC ULTRASOUND; SURGICAL-MANAGEMENT; DIAGNOSIS; INSULINOMAS; LOCALIZATION; EXPERIENCE; ULTRASONOGRAPHY;
D O I
10.1016/j.gie.2014.12.031
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Current guidelines recommend CT scan or magnetic resonance imaging as the initial imaging modalities for the work-up of suspected pancreatic neuroendocrine tumors (PNETs). Objective: To determine the incremental benefit of preoperative EUS (IBEUS) for the detection of suspected PNETs after other investigative modalities have been attempted. Design: This systematic review searched MEDLINE, EMBASE, bibliographies of included articles, and conference proceedings for studies reporting original data regarding the preoperative detection of PNETs. Pooled IBEUS was calculated by using random effects models. Heterogeneity was explored by using stratified meta-analysis and meta-regression. Evidence of small-study effects was assessed by using funnel plots and the Begg test. Patients: Patients with suspected PNETs. Interventions: EUS evaluation. Main Outcome Measurements: The pooled IBEUS for the detection of PNETs after CT scan, with or without additional investigative modalities. Results: Among 4505 citations identified, we included 17 cohort studies (612 patients). EUS identified PNETs in 97% of cases. Improved PNET identification with EUS was observed in all of the studies. After adjusting for small-study effects, meta-analysis showed that EUS alone could identify PNETs in approximately 1 in 4 patients (adjusted IBEUS 26%; 95% confidence interval, 17%-37%). The pooled IBEUS varied based on the study design, study size, type of CT scan used, and the number of modalities used prior to EUS. Limitations: The majority of included studies were retrospective. Small-study effects were observed. Conclusion: Preoperative EUS is associated with an increase in PNET detection after other modalities are attempted.
引用
收藏
页码:848 / +
页数:10
相关论文
共 41 条
[1]   The impact of preoperative endoscopic ultrasound on the surgical management of pancreatic neuroendocrine tumours [J].
Alsohaibani, Fahad ;
Bigam, David ;
Kneteman, Norman ;
Shapiro, A. M. James ;
Sandha, Gurpal Singh .
CANADIAN JOURNAL OF GASTROENTEROLOGY, 2008, 22 (10) :817-820
[2]  
Andronesi D, 2009, CHIRURGIA-BUCHAREST, V104, P675
[3]   Pancreatic cystic neuroendocrine tumors: Preoperative diagnosis with endoscopic ultrasound and fine-needle immunocytology [J].
Baker, Marshall S. ;
Knuth, Jamie L. ;
DeWitt, John ;
LeBlanc, Julia ;
Cramer, Harvey ;
Howard, Thomas J. ;
Schmidt, C. Maxwell ;
Lillemoe, Keith D. ;
Pitt, Henry A. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (03) :450-456
[4]   Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours [J].
Buchmann, I. ;
Henze, M. ;
Engelbrecht, S. ;
Eisenhut, M. ;
Runz, A. ;
Schaefer, M. ;
Schilling, T. ;
Haufe, S. ;
Herrmann, T. ;
Haberkorn, U. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (10) :1617-1626
[5]  
Clark OH, 2009, J NATL COMPR CANC NE, V7, P712
[6]  
De Angelis C, 1999, Eur J Ultrasound, V10, P139, DOI 10.1016/S0929-8266(99)00054-3
[7]   Well-differentiated pancreatic tumor/carcinoma:: Insulinoma [J].
de Herder, Wouter W. ;
Niederle, Bruno ;
Scoazec, Jean-Yves ;
Pauwels, Stanislas ;
Kloeppel, Guenter ;
Falconi, Massimo ;
Kwekkeboom, Dik J. ;
Oberg, Kjel ;
Eriksson, Barbro ;
Wiedenmann, Bertram ;
Rindi, Guido ;
O'Toole, Dermot ;
Ferone, Diego .
NEUROENDOCRINOLOGY, 2006, 84 (03) :183-188
[8]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]   NEUROENDOCRINE PANCREATIC TUMORS - CLINICAL PRESENTATION, BIOCHEMICAL AND HISTOPATHOLOGICAL FINDINGS IN 84 PATIENTS [J].
ERIKSSON, B ;
ARNBERG, H ;
LINDGREN, PG ;
LORELIUS, LE ;
MAGNUSSON, A ;
LUNDQVIST, G ;
SKOGSEID, B ;
WIDE, L ;
WILANDER, E ;
OBERG, K .
JOURNAL OF INTERNAL MEDICINE, 1990, 228 (02) :103-113
[10]   ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors [J].
Falconi, Massimo ;
Bartsch, Detlef Klaus ;
Eriksson, Barbro ;
Kloeppel, Guenter ;
Lopes, Jose M. ;
O'Connor, Juan M. ;
Salazar, Ramon ;
Taal, Babs G. ;
Vullierme, Marie Pierre ;
O'Toole, Dermot .
NEUROENDOCRINOLOGY, 2012, 95 (02) :120-134